The protective mechanism of Tao Hong Si Wu decoction against breast cancer through regulation of EGFR/ERK1/2 signaling

Ethnopharmacological relevance: Tao Hong Si Wu Decoction (THSWD), a traditional Chinese herbal medicine, is widely utilized in clinical settings, either alone or in combination with other medications, for the treatment of breast Cancer.

Aim of the study: The specific targeting molecule(s) of THSWD and its associated molecular mechanisms remain unclear. This research aims to elucidate the underlying molecular mechanisms of THSWD in the treatment of breast Cancer.

Materials and methods: The pharmacological properties of THSWD were investigated in breast Cancer cells and tumor tissues using a range of methods including Acridine Orange/Ethidium Bromide (AO/EB) staining, Transwell assay, flow cytometry, immunofluorescence assay, and breast Cancer mice models.

Results: Our findings demonstrate that THSWD induces necrosis and/or Apoptosis in breast Cancer cells, while significantly inhibiting cell migration. Target proteins of THSWD in Anticancer activity include EGFR, Ras, and Others. THSWD treatment for breast Cancer is associated with the EGFR/ERK1/2 signaling pathway.

Conclusion: Our findings offer initial insights into the primary mechanism of action of THSWD in breast Cancer treatment, indicating its potential as a complementary therapy deserving further investigation.

Apoptosis; Breast cancer; EGFR/ERK1/2; MMTV-PyMT; THSWD; Traditional Chinese medicine.